Cancer Communications (Jan 2024)

Harnessing SARS‐CoV‐2‐specific CD8+ T cells to kill target tumor cells for cancer immunotherapy

  • Keunok Jung,
  • Deok‐Han Ko,
  • Jeong‐Yun Jang,
  • Young Rong Kim,
  • Jung Yeon Heo,
  • Yong‐Sung Kim

DOI
https://doi.org/10.1002/cac2.12497
Journal volume & issue
Vol. 44, no. 1
pp. 173 – 177

Abstract

Read online

No abstracts available.